Drug recall · April 25, 2018
Triamterene and Hydrochlorothiazide Tablets recall
Why: Cross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisinopril, Mannitol, Iron, Calcium and Phosphorous).
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured by Sandoz, Inc., Princeton, NJ 08540, NDC 0781-5067-05.
- Lots / codes
Lot #: GW8264, HD3095, Exp 12/18
- Quantity
- 11,680 bottles
- Company
- Sandoz Incorporated, Broomfield, CO
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- April 6, 2018 · Voluntary: Firm initiated
- Classified
- April 16, 2018
- Reported
- April 25, 2018
- Ended
- April 8, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.